Freestone Grove Partners LP Boston Scientific Corp Transaction History
Freestone Grove Partners LP
- $9.71 Trillion
- Q1 2025
A detailed history of Freestone Grove Partners LP transactions in Boston Scientific Corp stock. As of the latest transaction made, Freestone Grove Partners LP holds 3,187 shares of BSX stock, worth $316,596. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,187
Previous 298,953
98.93%
Holding current value
$316,596
Previous $26.7 Billion
98.8%
% of portfolio
0.0%
Previous 0.33%
Shares
2 transactions
Others Institutions Holding BSX
# of Institutions
1,832Shares Held
1.21BCall Options Held
9.66MPut Options Held
6.98M-
Vanguard Group Inc Valley Forge, PA135MShares$13.4 Billion0.25% of portfolio
-
Black Rock Inc. New York, NY126MShares$12.6 Billion0.22% of portfolio
-
State Street Corp Boston, MA64.5MShares$6.41 Billion0.28% of portfolio
-
Primecap Management CO Pasadena, CA36.5MShares$3.63 Billion3.11% of portfolio
-
Wellington Management Group LLP Boston, MA33.2MShares$3.3 Billion0.67% of portfolio
About BOSTON SCIENTIFIC CORP
- Ticker BSX
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,431,609,984
- Market Cap $142B
- Description
- Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...